icon-folder.gif   Conference Reports for NATAP  
 
  64rd Annual Meeting of the
American Association for the
Study of Liver Diseases
Washington, DC Nov 1-5 2013
Back grey_arrow_rt.gif
 
 
 
Sustained Immune Control in HBeAg-Positive Chronic Hepatitis B Patients Who Switched From Long-Term Entecavir Therapy to Peginterferon Alfa-2a (40KD): 1-Year Follow-Up of the OSST Study
 
 
  Reported by Jules Levin
AASLD 2013 Nov 1-5 Wash DC
 
M. Han,1 J. Jiang,2 J. Hou,3 D. Tan,4 Y. Sun,5 M. Zhao,6 Q. Ning;1 on behalf of the OSST study group
1Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; 2The First Hospital, Fujian Medical University, Fuzhou, China; 3Nanfang Hospital, Nanfang Medical University, Guangzhou, China;4Xiangya Hospital, Central South University, Changsha, China; 5Tangdu Hospital, The Fourth Military Medical University, Xi'an, China; 6Shanghai Roche Pharmaceuticals Co., Ltd, Shanghai, China

AASLD1.gif

AASLD2.gif

AASLD3.gif

AASLD4.gif

AASLD5.gif

AASLD6.gif

AASLD7.gif

AASLD8.gif

AASLD9.gif

AASLD10.gif

AASLD11.gif

AASLD12.gif

AASLD13.gif

AASLD14.gif